Meridian Bioscience Inc.
VIVO
Market Cap$1.49B
Close$
$35.10
3.3% upside
Current Fair Value
3.3% upsideUndervalued by 3.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.49 Billion |
|---|---|
| Enterprise Value | $1.45 Billion |
| Dividend Yield | $9.882086 (0%) |
| Earnings per Share | $0.96 |
| Beta | 0 |
| Outstanding Shares | 43,896,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 35.21 |
|---|---|
| PEG | -11.96 |
| Price to Sales | 5.66 |
| Price to Book Ratio | 4.85 |
| Enterprise Value to Revenue | 4.8 |
| Enterprise Value to EBIT | 55.47 |
| Enterprise Value to Net Income | -536 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Meridian Bioscience Inc.
CEO: John Kenny